Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
The Indian government has strengthened oversight of cell and gene therapies by bringing the novel modalities into the ...
Industry and academic stakeholders have asked the US Food and Drug Administration (FDA) to clarify its objectives and plans for a proposed pilot program to evaluate how artificial intelligence (AI) ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This week, ...
Notified body association Team-NB has suggested changes to the European Commission’s proposals for risk-adaptive surveillance ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
AI hallucinations are the central unsolved problem for deploying language models in regulated industries: medical devices, clinical decision support, drug discovery, and post-market surveillance.
<i>Regulatory Focus</i> is the only source of timely, quality news and information fully dedicated to daily online coverage of the global regulation of healthcare products. An experienced team of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results